Wuhan YZY Biopharma Co., Ltd. Class H(HK:2496)
HK$4.000.00 (0.00%)
HK:2496
Wuhan YZY Biopharma Co., Ltd. Class H financials statements
HK$4.00
At close:0.00 (0.00%)
Want to see HK:2496 full AI Analyst Report?
Wuhan YZY Biopharma Co., Ltd. Class H (2496) Financial Statements
1 Followers
Wuhan YZY Biopharma Co., Ltd. Class H Financial Overview
Wuhan YZY Biopharma Co., Ltd. Class H's market cap is currently ¥1.05B. The company's EPS TTM is ¥-0.24; its P/E ratio is -13.89; Wuhan YZY Biopharma Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 65.13M | ¥ 107.81M | ¥ 11.92M | ¥ 2.28M | ¥ 12.18M |
| Gross Profit | ¥ 6.17M | ¥ 85.07M | ¥ 11.92M | ¥ 2.28M | ¥ 12.18M |
| Operating Income | ¥ -87.93M | ¥ -98.00M | ¥ -177.37M | ¥ -175.58M | ¥ -132.23M |
| EBITDA | ¥ -83.49M | ¥ -86.95M | ¥ -157.46M | ¥ -168.63M | ¥ -124.61M |
| Net Income | ¥ -82.54M | ¥ -97.60M | ¥ -190.98M | ¥ -188.87M | ¥ -148.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 100.11M | ¥ 126.28M | ¥ 196.68M | ¥ 200.52M | ¥ 83.71M |
| Total Assets | ¥ 175.08M | ¥ 267.84M | ¥ 301.62M | ¥ 302.84M | ¥ 200.16M |
| Total Debt | ¥ 127.81M | ¥ 127.35M | ¥ 90.11M | ¥ 76.67M | ¥ 28.48M |
| Net Debt | ¥ 27.70M | ¥ 1.08M | ¥ -106.57M | ¥ -67.48M | ¥ -39.32M |
| Total Liabilities | ¥ 228.13M | ¥ 237.31M | ¥ 173.97M | ¥ 146.96M | ¥ 56.99M |
| Stockholders' Equity | ¥ -53.05M | ¥ 30.54M | ¥ 127.65M | ¥ 155.88M | ¥ 143.16M |
| Cash Flow | |||||
| Free Cash Flow | ¥ -22.46M | ¥ -102.22M | ¥ -187.95M | ¥ -156.40M | ¥ -82.10M |
| Operating Cash Flow | ¥ -21.57M | ¥ -100.72M | ¥ -186.02M | ¥ -176.70M | ¥ -98.71M |
| Investing Cash Flow | ¥ -130.00K | ¥ -4.67M | ¥ 54.81M | ¥ 5.80M | ¥ -19.93M |
| Financing Cash Flow | ¥ -4.68M | ¥ 33.02M | ¥ 176.29M | ¥ 241.33M | ¥ 81.03M |
Currency in CNY
